CIK 0002131524 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-10 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-09-08 | 10-Q | 10-Q | 2026-06-30 |
| 2026-09-08 | 8-K | 8-K items 2.02,9.01 | 2026-09-08 |
| 2026-08-18 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-08-14 | 3 | 3 | 2026-08-07 |
| 2026-08-14 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-11 | 4 | 4 | 2026-08-07 |
| 2026-08-11 | 4 | 4 | 2026-08-07 |
| 2026-08-11 | 4 | 4 | 2026-08-07 |
| 2026-08-10 | 4 | OWNERSHIP DOCUMENT | 2026-08-07 |
| 2026-08-07 | 4 | 4 | 2026-08-07 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 4 | FORM 4 | 2026-08-05 |
| 2026-08-07 | 8-K | 8-K items 5.03,9.01 | 2026-08-05 |
| 2026-08-06 | S-8 | S-8 | |
| 2026-08-06 | 424B4 | S-1/A | |
| 2026-08-06 | CERT | CERT |
Forms on file (last 1,000): 3 15, 4 14, 8-K 2, SCHEDULE 13D 2, SCHEDULE 13D/A 1, 10-Q 1, SCHEDULE 13G 1, S-8 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=BRVE (0.002 USD), /gw/filings/filings?ticker=BRVE&form=8-K, /gw/filings/facts?ticker=BRVE&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange